Your Marketing & BD Infrastructure
What you're looking at is your complete marketing and business development infrastructure — not a content calendar, not a brand guidelines document, but a structured, usable foundation that defines who you serve, how you're positioned, how you communicate, and how you compete. This is the strategic layer that makes every downstream activity — content, proposals, new hire onboarding, agency briefings, website copy — consistent and intentional.
This was built from everything you shared in your intake, cross-referenced with your published website and materials. The intake was the starting point, not the endpoint. Where we found gaps, we flagged them. Where sources agreed, we built from them with confidence. Where they pointed in different directions, we explain how we resolved it.
Your job is to confirm that what we found is accurate. Use the notes fields to tell us where something doesn't match how you see your business. That confirmation activates the infrastructure and makes it yours.
Here is how your Backbone Framework is structured — what went in, what frameworks were applied, what you receive, and what you can do with it.
The six context files are yours. Any tool, any team member, any agency you ever work with can use them as the source of truth for how your business communicates and competes.
We reviewed your complete Backbone intake responses, your website (goodbonesmarketing.com — homepage, services, about, process, and client testimonial), and your marketing flyer (GBM-Flyer3.pdf). No content examples or past posts were submitted, so voice analysis was derived from intake responses and published materials. We note where this limitation matters.
Identifying buyers most likely to convert, retain, and refer — from firmographic and psychographic data, not assumptions.
The Big Five personality model applied to calibrate how content and messaging should be written for each buyer segment's psychology.
Tracing how each buyer type moves from problem awareness to purchase decision — identifying what they need to see at each stage.
Defining the emotional role your brand plays in your audience's lives — guiding voice, tone, and register across all communications.
Identifying not just competitors, but what buyers try before finding you — and why those approaches fall short.
Structured evaluation of sentence patterns, diction, tone, and structural habits across all available published materials.
The gap between your actual credentials and their current visibility. Credential-rich, community-embedded, structurally differentiated — but not yet consistently findable by the buyers who need you most.
Twenty years of community membership plus AI infrastructure that stays with the client. That combination is genuinely difficult for any agency or generic tool to replicate.
Activate this infrastructure and make you findable to buyers already experiencing the problems you solve. The strategic foundation is clear. Visibility is what needs to close.
Your business has a positioning problem that is the opposite of the one most marketing consultants describe. You are not underqualified for your market. You are one of the most credibly positioned people in the life sciences AEC and supplier community. Twenty years inside the industry, CPSM certification, ISPE chapter president, SMPS award winner, fifteen-plus Facility of the Year entries for major accounts. The credentials are not the gap. The gap is visibility — specifically, the gap between how well-positioned you actually are and how visible that positioning is to the buyers who would most benefit from your work.
Your infrastructure is now documented. What you do with it is up to you.
Two separate analyses: the first maps your position against the market at large; the second names your specific competitors and shows exactly where each one is a threat and where each one is an opening.
Built from your intake responses, your published materials, and external market research conducted across the AEC, life sciences construction, and B2B marketing automation sectors. Strengths and Weaknesses are internal — things your business controls, independent of any competitor. Opportunities reflect market conditions and buyer gaps that exist regardless of who else is in the market. Threats are structural forces — industry dynamics, buyer behavior patterns, and macro risks — that apply whether a named competitor exists or not.
- CPSM + ISPE Delaware Valley Chapter President + SMPS award winner — community credibility that cannot be manufactured without two decades inside the industry
- "Systems That Stay" delivery model builds permanent client-owned assets, not retainer dependency — structurally different from every alternative a buyer would evaluate
- Deep GMP / CQV / EPCM regulatory literacy means content passes the technical review that generic agency output consistently fails
- Former Director of Marketing at a billion-dollar Berkshire Hathaway firm — C-suite fluency when selling to enterprise and senior leadership
- ERA Science testimonial approved for public use — one validated proof point in a market where most proof is contractually silenced
- Blueprint to Batch podcast — direct editorial access to target buyer titles in a non-sales context that organic content cannot replicate
- Solo operator: capacity, delivery, and BD all depend on one person — the ceiling is the founder's available hours, full stop
- NDA constraints prevent naming pharma and biotech facility clients — social proof is limited in the market where peer validation carries the most weight
- No published case studies with hard ROI data — risk-averse enterprise buyers want quantified outcomes before committing
- Early revenue stage ($80K) limits budget for conference visibility, paid acquisition, and contractor support
- Pricing not publicly disclosed — creates self-qualification friction for buyers who research extensively before reaching out
- Website voice runs more formal than the brand's actual register — misaligns the first impression with the live engagement experience
- FDA and EMA AI guidance expanding rapidly — creating an urgent compliance question that the vast majority of marketing vendors cannot answer credibly
- Life sciences construction at decade highs driven by biopharma capacity buildout — AEC and EPCM firms are growing fast and their marketing infrastructure is not keeping up
- Senior engineer retirement wave at client firms creating an institutional knowledge crisis — the AI Knowledge Base product directly addresses a problem buyers are actively feeling
- Existing ISPE + SMPS community position enables warm introductions at near-zero acquisition cost — trust channels that take years to build are already in place
- Podcast guest relationships represent an untapped BD pipeline — conversations that haven't been converted to client exploration
- B2B buyers in regulated industries are increasingly skeptical of generic AI outputs — creating demand for domain-validated, compliance-aware automation that the market has not filled
- Large EPCM and AEC firms with dedicated IT budgets beginning to build internal AI and marketing automation teams — reducing the window where an external specialist is the default choice
- IT and legal departments structurally blocking AI vendor access — deals stall after champion engagement, not because of fit; the champion cannot close without clearing internal gatekeepers
- Generalist AI platforms (ChatGPT Enterprise, Microsoft Copilot) providing "good enough" automation for buyers who have not experienced what a validated, domain-specific system delivers
- Long B2B sales cycles in regulated industries — the gap between first engagement and closed deal creates revenue timing risk for a solo operator
Built from competitive intelligence gathered during the framework research phase, cross-referenced with named competitors in your intake. For each competitor, we identified what they do well (Threats that require a counter-strategy) and where they fall short (Opportunities to exploit in positioning and content). This analysis is specific to the three competitors you named: Forma Life Science Marketing, Altitude Marketing, and Gorilla 76.
- vs. Forma CPSM credential + active ISPE Chapter President — association standing Forma cannot replicate; buyers in this community know the difference
- vs. Forma "Systems That Stay" model delivers client-owned AI infrastructure — Forma delivers content on retainer with nothing permanent left behind
- vs. Altitude Deep EPCM and GMP-specific regulatory literacy — Altitude's life sciences work addresses commercial biotech brands, not proposal marketing and facility delivery
- vs. Altitude AI Automation Systems as a discrete, defined service line — Altitude has no equivalent offering in regulated AEC
- vs. Gorilla 76 ISPE + SMPS community access and regulatory credibility — Gorilla 76 has strong industrial B2B presence but zero penetration into life sciences construction
- vs. Gorilla 76 Domain-validated AI systems for GMP environments — Gorilla 76 cannot serve a client whose IT requires compliance-documented AI inputs
- vs. Forma Scale — Forma has a full agency team; Sandra is a solo operator with a hard capacity ceiling that Forma does not have
- vs. Forma Established pharma and biotech client relationships with multi-year tenure — displacing a trusted vendor requires a compelling event, not just a better offer
- vs. Altitude National brand recognition in life sciences marketing — Altitude has built visible market presence over more years and with more team resources
- vs. Altitude Full-service breadth — Altitude covers strategy, brand, digital, and execution under one contract; GBM is specialists-only
- vs. Gorilla 76 Published content marketing volume and podcast scale — Gorilla 76 has built a recognizable industrial B2B content brand with more production output than GBM currently generates
- vs. Forma No AI automation capability — Forma operates entirely on a traditional retainer model; buyers who want client-owned systems get nothing from them
- vs. Forma No "Systems That Stay" positioning — any buyer who has experienced retainer dependency is a conversion candidate when they see the alternative framed clearly
- vs. Altitude Not EPCM or proposal-marketing specific — their life sciences practice doesn't address the shortlist and RFP layer where Sandra's domain expertise lives
- vs. Altitude No ISPE or SMPS community standing — buyers who rely on association relationships for vendor validation have no warm path to Altitude
- vs. Gorilla 76 Has not penetrated life sciences AEC — their industrial positioning stops at general manufacturing; no GMP, no ISPE, no regulated facility context
- vs. Gorilla 76 Cannot serve clients requiring compliance-documented AI — any buyer whose IT department requires validated AI inputs is outside Gorilla 76's current capability
- Forma Deep pharma and biotech client roster with multi-year relationships — the buyer who has already worked with Forma has loyalty and switching cost working against you
- Forma Adding AI capabilities — if Forma develops an AI service line, the differentiation gap on automation narrows and the established relationship advantage compounds
- Altitude Full-service appeal for enterprise buyers who want a single vendor — the "one agency for everything" pitch is a strong alternative for a buyer who hasn't yet identified AI infrastructure as a distinct need
- Altitude National brand recognition creates shortlist presence by default — Sandra has to earn that shortlist position in each new opportunity
- Gorilla 76 Proven content marketing playbook for industrial B2B — a buyer in adjacent industrial markets who finds Gorilla 76 first may not realize life sciences AEC marketing requires a different specialist
- Gorilla 76 Expanding into adjacent regulated verticals — if they move toward pharma AEC with intentionality, the white space narrows
| Competitor | Their Biggest Threat to You | Your Biggest Opening vs. Them | How to Win the Comparison |
|---|---|---|---|
| Forma Life Science Marketing | Established multi-year client relationships in pharma and biotech AEC — high switching cost once embedded | No AI automation capability; no "Systems That Stay" model — buyers who want owned infrastructure get nothing from Forma | Lead with the structural difference: Forma builds content on your behalf; GBM builds infrastructure that belongs to you after the engagement ends |
| Altitude Marketing | Full-service breadth and national life sciences brand recognition — attractive single-vendor option for buyers who haven't isolated AI infrastructure as a need | Not EPCM or GMP-specific; no ISPE community standing — the proposal marketing and facility delivery layer is a gap they do not fill | Lead with the EPCM layer: CPSM + GMP/CQV regulatory literacy is a credential stack Altitude cannot replicate without industry years inside AEC |
| Gorilla 76 | Proven industrial B2B content brand with high production volume — buyers in adjacent markets may find them first | Zero life sciences AEC penetration; no ISPE presence; cannot serve compliance-document-requiring AI buyers | Own the ISPE + SMPS community channel explicitly and publicly — your association standing is the one advantage Gorilla 76 cannot manufacture or accelerate |
Your Audience
Five buyer profiles — one for every audience segment you listed in your intake — built from ICP methodology and psychographic analysis, including how each segment moves through their buying journey and which services apply to each.
Post-pandemic reshoring of pharmaceutical manufacturing and cell/gene therapy scale-up is accelerating EPCM and cleanroom construction pipelines through 2028. Firms that cannot demonstrate validated facility delivery credentials face early disqualification from clinical-to-commercial mandates, raising the credibility floor for every marketing touchpoint in this segment.
AEC and Facility Delivery Firms
Who They Are
Architecture, engineering, construction management, and specialty contracting firms that design, build, and commission life sciences facilities — EPCM firms, MEP engineers, cleanroom contractors, CQV specialists. The buyer is the VP of Marketing or Director of BD — often the only dedicated marketing person in the firm, responsible for everything from capability statements to ISPE award submissions.
What Makes Them Ready to Engage
- Lost a proposal shortlist to a competitor with weaker credentials but stronger marketing materials
- New VP of BD or Director of Marketing joined in the last 90 days and inherited a program they didn't build
- An ISPE Facility of the Year award cycle is approaching and the firm wants to submit or improve
- The marketing person just left and leadership is deciding whether to hire again or restructure
- The firm won a marquee project and no content plan exists to build visibility around it
- A peer firm they respect just launched content that their own program doesn't match
What They Need to Believe
That you are genuinely inside their community, not learning it on their engagement. And that what you build will sound like them — not like a marketing agency's version of them.
Where to Reach Them
Psychographic Profile (OCEAN)
Who They Are
The VP of Marketing at an EPCM or life sciences AEC firm owns everything from capability statements to award submissions. They are usually the most senior dedicated marketing person in the building — and often the only one. They are accountable for how the firm looks on paper, on LinkedIn, and in front of a client selection committee. When a proposal shortlist is missed, they feel it personally. When the firm wins a marquee project and generates no content around it, they know exactly why.
What Triggers Them to Act
- Firm lost a shortlist to a competitor with weaker technical credentials but stronger marketing materials
- CEO or Managing Director asked why the firm isn't more visible at ISPE events
- New strategic plan includes market expansion and the marketing capability doesn't exist to support it
- An ISPE Facility of the Year cycle is approaching and the last submission was rejected or weak
- Senior marketing team member resigned and leadership is deciding whether to rebuild or restructure
What They Need to Believe
That you already understand their market before the first call — and that the systems you build will still be running and improving long after the engagement ends.
Their Personal Stakes
Their job security is tied to proposal win rates and market visibility. A failed agency engagement doesn't just waste budget — it costs them credibility with the BD Director and the CEO. They need a vendor who can walk into a room of engineers and speak their language without being briefed.
How They Make Decisions
Methodical. High conscientiousness — they will research Sandra's LinkedIn, check her ISPE profile, read her posts for six weeks before reaching out. They want written materials, not a sales call. Peer validation matters: if someone in their SMPS network has worked with Sandra, that reference carries more weight than any case study.
What They've Already Tried
A general B2B marketing agency that didn't understand cleanrooms or proposal language. A freelance copywriter who required six rounds of technical editing. Internal staff stretched too thin. They've tried enough to know that domain depth is non-negotiable — what they haven't found is a vendor who combines it with AI infrastructure.
Who They Are
The Director of BD at an EPCM or AEC firm is measured on pipeline — specifically on proposal win rates, qualified opportunity volume, and new market penetration. They live in the RFP cycle. They know every competitor they lost to last quarter. They are the internal champion for anything that improves proposal quality, accelerates response time, or opens new market relationships. They own the relationship with clients and prospects — and they feel the cost of a weak marketing infrastructure directly, in the room, during selection presentations.
What Triggers Them to Act
- Proposal win rate dropped below target last quarter and leadership is asking why
- Firm expanding into a new geography or project type where their marketing presence is zero
- Manual RFP response process is consuming 60+ engineer hours per submission
- A key senior engineer retired and six months of institutional project knowledge left with them
- Competitor is showing up at ISPE events and on LinkedIn with visible market presence; their firm isn't
- New joint venture or teaming partnership requires professional marketing materials that don't exist
What They Need to Believe
That this isn't a content production engagement. That what gets built is a BD infrastructure — proposal intelligence, market monitoring, and a knowledge base that makes the next RFP take half the time.
Their Personal Stakes
Win rates. Revenue pipeline. If they champion an AI or marketing vendor and it produces generic output that embarrasses the firm in front of a client selection committee, it lands on them. They need something that works in the room with a VP of Engineering — not something that looks good in a demo.
How They Make Decisions
More decisive than the VP of Marketing but still relationship-driven. Will ask a peer at ISPE or SMPS if they've worked with Sandra. Wants to understand the ROI in pipeline terms — "what does this do for our proposal win rate?" — before any conversation about process or methodology. Responds well to specificity: name the exact RFP pain, the exact proposal bottleneck, the exact competitive intelligence gap.
What They've Already Tried
They've tried asking the marketing person to solve a sales problem. They've had engineers write their own proposal content (slow, painful, generic). They may have tried a proposal management tool or a CRM that didn't integrate with how the BD team actually works. They know what the gap is — they've been living with it for years.
The industry-wide shift from stainless steel to single-use bioprocessing infrastructure is compressing equipment replacement cycles and opening new supplier entry points at Tier 1 pharma accounts. Suppliers that cannot demonstrate regulatory compliance credibility in their marketing materials face early-stage disqualification from strategic account evaluations before formal procurement opens.
Systems, Equipment, and Materials Suppliers
Who They Are
Manufacturers and OEMs selling capital equipment, automation systems, single-use technologies, cleanroom components, and GMP-critical products to the life sciences facilities the first segment builds and operates. The buyer is typically the VP of Sales or CEO — running marketing as a side responsibility and now needing a system that matches the firm's growth ambitions.
What Makes Them Ready to Engage
- Major trade show approaching (CPhI, ISPE, Interphex) and digital presence doesn't match event presence
- New VP of Sales or BD Director joined with a mandate to modernize go-to-market
- A competitor just published visible, professional content that made the contrast uncomfortable
- Entered a new product category with no marketing foundation for the new offering
- A strategic account asked for a capability overview and the firm scrambled to produce materials
What They Need to Believe
That investing in marketing infrastructure will generate pipeline — tied to how strategic accounts find and evaluate suppliers before they ever reach out.
Where to Reach Them
Psychographic Profile (OCEAN)
Who They Are
The VP of Sales at a capital equipment OEM is measured on pipeline -- specifically on new account acquisition, strategic account penetration, and trade show ROI. They know every competitor who showed up at CPhI with a polished content presence; they felt that comparison firsthand. They are the internal champion for any go-to-market improvement that gives the sales team leverage without adding headcount. And they know the ceiling on relationship-driven selling: it is the size of their personal network.
What Triggers Them to Act
- Major trade show approaching with no supporting digital presence to extend the event investment
- Entered a new market segment or geography where pipeline is zero and the personal network doesn't reach
- Lost a strategic account evaluation to a competitor with weaker technical specs but stronger marketing credibility
- CEO asked why pipeline isn't growing at the rate the engineering quality should justify
- A strategic account asked for a capability overview document that didn't exist in any usable form
What They Need to Believe
That content infrastructure will generate inbound from strategic accounts before the next evaluation cycle begins -- and that the ROI is measurable in pipeline terms, not marketing metrics.
Their Personal Stakes
Win rates and strategic account penetration. If they champion a marketing investment that produces generic content embarrassing the firm in front of a Tier 1 procurement team, it lands on them directly. They need something that survives contact with a VP of Engineering or a procurement committee, not something that looks impressive in a demo.
How They Make Decisions
More direct than AEC buyers. Fewer committee layers. Responds to pipeline ROI framing over methodology. Wants to see proof fast -- the ERA Science case is the asset that opens the conversation. Will ask: "Has this worked for a company in our space?" before any discussion of process.
What They've Already Tried
A founder-managed brand that doesn't scale to their ambitions. A general B2B agency without life sciences regulated-environment knowledge that required constant re-education. Sporadic trade press releases that didn't build a pipeline. They know what's missing -- a system that gives the sales team marketing leverage before every strategic account conversation.
Who They Are
The CEO of a founder-built OEM built the company on technical excellence and personal relationships. Marketing has been their side project for a decade. They are proud of the product and the engineering team behind it. They are increasingly aware that the company's growth ceiling is tied to visibility with accounts that don't already know them -- and that the VP of Sales they just hired needs marketing support they don't have a system to provide.
What Triggers Them to Act
- Hired a new VP of Sales who is asking for marketing infrastructure the company doesn't have
- Entering a new geography or product category with no marketing foundation to support it
- A strategic account asked for a comprehensive capability overview that didn't exist in any form
- Trade show investment isn't converting to strategic account relationships at the rate the investment justifies
- A competitor they consider technically inferior published content that made them look like the authority first
What They Need to Believe
That a system built on their firm's actual language, technical specifications, and regulatory context will produce content their engineering team respects -- not content the team has to correct before they'll allow it out the door.
Their Personal Stakes
The brand IS their reputation. They will not associate with a marketing system that oversimplifies or misrepresents their product line. Their engineering team's credibility with Tier 1 accounts is what they protect above everything else. A single piece of inaccurate marketing content in front of a strategic account's procurement team is worse than no marketing at all.
How They Make Decisions
Direct budget authority -- can move faster than AEC buyers with fewer approval layers. But highly protective of brand accuracy. Will want to see output their engineering team won't correct before agreeing to anything. The conversation that matters isn't ROI -- it's "will this sound like us?" If the output quality passes, the decision is fast.
What They've Already Tried
Done it themselves with inconsistent discipline for years. Occasional trade press piece that didn't build pipeline. A junior team member managing LinkedIn with no strategy and no system behind it. They've built an excellent company -- they've just never built a marketing infrastructure to match it.
FDA's Case for Quality initiative and the proliferation of remote inspection protocols are forcing life sciences firms to modernize quality systems infrastructure faster than internal teams can manage. CQV and eQMS specialists with visible, technically credible content pipelines are capturing demand that was previously invisible to their markets, while firms without a content strategy remain dependent on a referral network that saturates over time.
Digital, Quality, and Compliance Infrastructure Firms
Who They Are
CQV specialists, computerized system validation firms, data integrity providers, and LIMS/MES/eQMS vendors supporting regulated environments. Typically founded by a technical expert who built a consulting practice on deep domain expertise and has been growing through referrals. Their professional identity is precision and accuracy — in a market where errors have regulatory consequences.
What Makes Them Ready to Engage
- A competitor published a white paper on a regulatory topic the firm has more expertise in
- The founder is speaking at a conference and wants content that extends the impact
- New FDA or EMA guidance was published and the firm is well-positioned to respond — but hasn't
- Expanding from consulting into software or entering a new geography
- A major engagement concluded and the firm wants visibility around what was accomplished
How They Decide
The most conservative of the three segments. Content that oversimplifies their work will disqualify you faster than any objection. The most effective approach is technical, substantive, and regulation-aware. Regulatory commentary, specific arguments defended with the vocabulary of the field.
Where to Reach Them
Psychographic Profile (OCEAN)
Who They Are
The CEO or founder of a CQV consulting firm, CSV specialist, or eQMS vendor built the company on deep technical precision. They know their regulatory subject matter better than anyone in the room. Their professional identity is built on the accuracy and rigor of their work -- and their biggest fear is that marketing will make them look like everyone else in a space where differentiation is built entirely on demonstrated depth. They have watched less rigorous competitors claim authority on topics they have spent a decade mastering.
What Triggers Them to Act
- A competitor published a white paper on a regulatory topic the firm has more expertise in -- and it generated visibility they didn't
- FDA or EMA published new guidance they are well-positioned to interpret, but they have no distribution channel to respond
- The founder is speaking at a conference with no content strategy to extend the impact beyond the room
- A major client engagement concluded with outstanding results that nobody outside that client knows about
- Expanding into a new geography or regulatory framework with no marketing infrastructure to announce it
What They Need to Believe
That a marketing system can represent their technical depth accurately and consistently -- and that building it will not require continuous correction from their team to keep it from misrepresenting their expertise.
Their Personal Stakes
Their technical reputation is their entire competitive advantage. They will not associate with content that misuses regulatory language, oversimplifies validation protocols, or makes claims their team cannot stand behind. A single technically inaccurate piece of content in the wrong hands destroys credibility they have spent a decade building. The downside risk of getting marketing wrong is more visible to them than the upside of getting it right.
How They Make Decisions
Slow and deliberate. The most conservative buyer across all three core segments. Will read Sandra's published content carefully for technical accuracy before considering a conversation. A single imprecise claim ends the evaluation. May take months at the evaluation stage -- not because of budget or approval layers, but because the trust threshold is extremely high. Often starts with a narrow, well-defined project to test output quality before committing to a system.
What They've Already Tried
Nothing structured. A junior team member asked to post on LinkedIn with inconsistent results. A white paper written by the founder that went nowhere because no distribution system existed. They know exactly what the output should look like -- they write it themselves when they have time. What they haven't found is a system that can produce that output without them doing it manually every time.
Who They Are
The VP of Business Development at a CQV or eQMS firm is rare. Most companies in this segment grew entirely on the founder's reputation and referral network. When this role exists, it signals the firm has crossed a growth threshold and is deliberately building a pipeline engine beyond personal relationships. They are typically constructing a BD function from scratch in a culture where technical rigor has always been the primary competitive asset and marketing has never been a structured priority.
What Triggers Them to Act
- Carries a revenue target with no systematic path to hit it -- the referral network is saturated
- Trying to expand into a new geography or regulatory framework where the firm has no existing relationships
- Needs content to support the founder's speaking schedule and translate conference presence into pipeline beyond the room
- Wants to generate inbound inquiries that don't depend on the founder being present in every conversation
- A competitor with lower technical credentials won a new account because their content positioned them as the authority first
What They Need to Believe
That marketing content can carry the firm's technical credibility to accounts that haven't met the founder -- and that building a content system won't create an ongoing liability for inaccuracy that the technical team has to manage.
Their Personal Stakes
Justify the existence of a BD function in a company that grew without one. They need the CEO or founder to trust that a marketing system won't dilute the firm's technical brand -- which means they must sell the investment internally before any external system can be built. Their internal selling motion mirrors their clients' own: a champion trying to move a technically conservative decision-maker to act on something they can't yet see the output of.
How They Make Decisions
Will champion the investment but cannot commit without founder buy-in. The bottleneck is the founder, not the budget. The most powerful framing is a business case the technical founder finds credible -- accuracy controls, output governance, and proof that the system won't produce content requiring engineering review before publication. Pipeline metrics matter: "what will this do for our inbound inquiry rate?"
What They've Already Tried
Relying on the founder's speaking schedule and personal reputation to generate pipeline. Attending conferences without supporting content to extend that presence beyond the room. Starting LinkedIn posts that die without a strategy or system behind them. They know what the gap looks like -- they feel it every quarter when pipeline reviews reveal that every lead came from one person's rolodex.
AI is restructuring agency pricing and delivery models faster than most principals anticipated. Agencies that productize AI workflows into a documented, client-facing capability command premium pricing and reduce competitive exposure to offshore content mills and AI-native competitors entering from adjacent markets.
Marketing Agencies
Who They Are
Small to mid-size marketing, digital, creative, and PR agencies whose owners built their practice on craft — and are now under pressure to integrate AI before clients start asking why they haven't. Often 1–25 employees. The buyer is the founder or managing partner, making the call independently. They've likely tried off-the-shelf AI tools and found the results generic. What they need is a real system, not a shortcut.
What Makes Them Ready to Engage
- A client asked "are you using AI?" and they didn't have a confident answer
- A competitor agency won a pitch by leading with AI capabilities
- Production costs are rising and they need leverage without adding headcount
- They tried to build AI workflows themselves and it took more time than it saved
- They want to offer AI-powered services to clients but don't know where to start
What They Need to Believe
That the system will make their work better without making it feel generic — and that the implementation won't require them to rebuild how they work from scratch.
Where to Reach Them
Psychographic Profile (OCEAN)
The barrier between small business owners and scalable content production is collapsing as AI infrastructure becomes accessible below the enterprise tier. Owners who build a systematized marketing approach early gain a compounding visibility advantage over competitors relying on ad hoc posting, and the cost of delay is increasingly visible in referral-dependent businesses whose networks are saturating.
Small Businesses and Entrepreneurs
Who They Are
Founders, solopreneurs, independent consultants, and small business owners who are doing marketing themselves or with a very small team. Excellent at their core work. Marketing takes a back seat. The buyer IS the decision-maker — there's no approval chain. They've likely tried ad hoc tools or sporadic social posting and found it inconsistent and exhausting. They don't need more content advice. They need a system that runs without them having to think about it every week.
What Makes Them Ready to Engage
- Referrals dried up and they realized visibility was entirely relationship-dependent
- Tried a marketing agency and found it too expensive for their stage — or too generic
- Peer business owner described what an AI system is doing for their marketing
- Spending hours per week on content with inconsistent results
- Want to grow but can't afford to hire a marketing person yet
What They Need to Believe
That the system will largely run without them once it's set up — and that it will sound like them, not like a robot. The single biggest fear is paying for something that produces content they're embarrassed to post.
Where to Reach Them
Psychographic Profile (OCEAN)
Your Competitive Position
Where you sit in the market, what sets you apart from every alternative your buyers have tried, and what you deliberately don't do. This is the positioning layer of your infrastructure.
Where You Sit in the Market
This map shows your position relative to the alternatives your buyers have already tried. The two axes that matter most for life sciences AEC and supplier buyers are industry depth and AI capability — because those are the two things generic agencies and generic tools consistently fail to deliver together.
Marketing
Tools
Agencies
Specialists
High specialist · High AI
High AI · Low specialist
Low AI · Low specialist
High specialist · No AI
What Sets You Apart
The reason a VP of BD at an EPCM firm will trust your analysis of their buyer, your understanding of their proposal process, and your judgment about what will and won't land in a GMP-facility client's inbox. When you describe a buyer's situation, you are describing what you have watched happen in ISPE committee rooms, on proposal review calls, and in the feedback loops of fifteen-plus Facility of the Year submissions.
The marketing and BD infrastructure built by Good Bones Marketing is trained on the client's own materials — their actual project descriptions, proposal language, case study vocabulary, brand voice. When the engagement ends, the infrastructure stays. The knowledge stays. No institutional knowledge walking out the door.
In a market where buyers evaluate partners through community membership and industry standing, these facts carry more weight than any case study. They signal permanent community membership — not a vendor who discovered life sciences marketing and is now positioning around it.
Most marketing firms are trying to add AI capabilities to existing service lines. Good Bones Marketing built the compliance governance layer first — because the regulated-environment buyer's primary objection to AI is known before any conversation even starts.
Buyers in your market do not make quick commitments to marketing partners. Offering a structured, free diagnostic that produces a specific, usable growth plan — before any engagement is proposed — removes commitment friction at exactly the right moment in the buying journey.
What You Replace
What You Don't Do — and Why That's a Strength
Good Bones Marketing does not serve pharmaceutical manufacturers, CDMOs, biotech companies, cell and gene therapy firms, hospitals, health systems, or medical device manufacturers. This boundary is not a limitation — it is the clearest possible signal of a specialist. The firms you serve are selling to these organizations. That means you are never in a position of divided loyalty. The clearest sign of expertise is what a firm says no to.
How the five competitive forces shape your position in the life sciences AEC marketing space. Click any force to see the full analysis and strategic implication.
A visual alignment of Good Bones Marketing's core revenue generators. Click any service bubble to see the full analysis. The matrix positions each service by market growth rate (vertical axis) and your current competitive position (horizontal axis).
Your Voice
The brand archetypes that define your role, the voice dimensions your communications sit on, and the writing rules applied across every output. This is the voice layer of your infrastructure — the rules that make your communications consistent regardless of who uses them.
Analysis Source
The voice analysis reviewed your complete intake responses, your published website (goodbonesmarketing.com — homepage, services, about, process, testimonial), and your marketing flyer (GBM-Flyer3.pdf). No LinkedIn posts or email samples were available. One notable finding: your intake described your voice as conversational, but your website reads as semi-formal. Your flyer is consistent with your intake description. We weighted the flyer and intake over the website copy — the website should be updated to align with your actual voice once the system is active.
Your Brand Archetypes
The trusted expert whose authority comes from depth of knowledge, not volume of presence. Calm, specific, credible. The communication that makes a VP of BD think "this person understands exactly what I'm dealing with."
Adds the dimension of building things rather than just advising. Systems, frameworks, and infrastructure that remain with the client. The practice is a workshop, not just a consultancy.
The orientation toward transformation — the before and the after, with the infrastructure as the mechanism. What changes isn't just the output. It's the underlying marketing capability.
Voice Spectrum
Where your brand communications sit on each dimension, based on analysis across all available materials. These calibrate how every piece of output should be written.
The Rules We Write By
These rules are applied to every output from your infrastructure. Edit any rule that doesn't match how you actually communicate, or add rules that are missing.
- We open with the point. Your audience is too experienced to sit through a build-up.
- We name specific problems. "Your marketing program lives in one person's head" is better than "marketing systems that lack resilience."
- We use your vocabulary correctly and without performing it. GMP, EPCM, CQV, ISPE, SMPS appear naturally when the audience expects them.
- We write as you, not as a firm. First person singular, because you are the practice.
- We end with something worth ending on — an observation, an invitation, the point itself. Not a summary.
- We never produce output that reads like AI generated it. If it sounds templated, it gets rewritten before it reaches you.
- We do not overstate. Your buyers will check claims. Every assertion has a basis.
How You'll Go to Market
Your infrastructure defines who you are. This section defines how you activate it. Channels, BD touchpoints, and a content strategy are all applications of the infrastructure you've just confirmed — not the infrastructure itself.
Primary Channel: LinkedIn
LinkedIn is where all three of your buyer segments actively evaluate vendors and partners. It is the channel where your industry credentials, community membership, and voice can work together. The strategy below is one application of your Backbone infrastructure — the same infrastructure can power proposals, capability statements, website copy, BD outreach, and any other output your team needs.
Recommended Content Mix
Platform: LinkedIn personal profile + company page
Cadence: Tuesdays & Thursdays + reactive
First Application: LinkedIn Content (8 Posts)
Your first content batch is one output from your infrastructure. Produced after you activate the system — you'll approve every piece before anything is published.
This is one application. The same infrastructure also powers your proposals, website, BD outreach, and any content your team needs to stay consistent.
Content Pillars
These five pillars structure the LinkedIn strategy. Each can be expanded with post ideas below. In edit mode, adjust counts or add ideas.
Builds authority and gives buyers a reason to follow. Demonstrates domain knowledge in specific, readable form.
- What the ISPE Facility of the Year Award actually measures — and what it says about a firm's marketing capability
- The one-person marketing department problem: why life sciences AEC firms keep rebuilding from scratch
- Why GMP-ready AI content is different from regular AI content (and how your buyers will know the difference)
- The proposal shortlist problem: what EPCM firms with strong credentials get wrong
Positions you as the named voice on AI governance in regulated environments and life sciences marketing strategy.
- The AI governance gap in life sciences marketing — and why generic tools create credibility risk for regulated-environment firms
- Twenty years of ISPE: what's changed about how regulated-environment buyers evaluate suppliers — and what hasn't
Converts warm leads. Each case study requires your explicit approval before use — no client is referenced without confirmation.
- How ERA Science went from scattered marketing to a consistent, recognizable presence in the life sciences AEC community
Growth Audit CTA or service reference. One promotional post per ten maintains credibility while creating a conversion opportunity.
- Growth Audit: a 90-minute session that maps exactly where your marketing program is losing pipeline — and what to do about it
Reactive — flagged as ISPE news, regulatory guidance, or industry events create the right moment. Positions you as someone actively watching what matters.
- New FDA AI guidance and what it actually means for marketing in GxP environments — a plain-language interpretation
- ISPE Annual Conference 2026: what life sciences AEC buyers are actually talking about this year
Event-Driven Activation Windows
| Event | Timing | Activation Angle |
|---|---|---|
| ISPE Annual Conference | June | Perspective on key themes; life sciences marketing lessons from the event |
| ISPE Facility of the Year Awards | Q3 – Q4 | Thought leadership on what award-winning projects teach about life sciences facility marketing |
| SMPS Annual Conference | July | BD and marketing best practices for AEC firms in technical markets |
| ISPE Delaware Valley Chapter Events | Quarterly | Local chapter content; founder's chapter president role creates native community visibility |
| FDA / EMA AI Guidance Releases | As published | Compliance-ready AI framing positioned around the new guidance |
Before We Activate
Seven items that need your confirmation before we finalize your infrastructure files and activate the system. Respond to each in the notes field below.
Your infrastructure covers all five segments you listed in your intake: (1) AEC and Facility Delivery firms as your primary segment, (2) Systems, Equipment, and Materials suppliers, (3) Digital, Quality, and Compliance infrastructure firms, (4) Marketing Agencies, and (5) Small Businesses and Entrepreneurs. Does this priority order match where you want your infrastructure focused in the next 12 months? And are there any segments where you want more or less content emphasis?
Your AI Automation Systems service serves all five segments, while Fractional Marketing Leadership is primarily positioned toward the life sciences segments. Confirm whether that split is accurate — and let us know if the content strategy should lean heavily toward one or two segments initially, or distribute evenly across all five.
- ERA Science / Andy O'Connor testimonial — currently the only confirmed, cleared reference. Please reconfirm it remains approved for use in infrastructure and output.
- "15+ ISPE Facility of the Year Award entries submitted on behalf of clients including WuXi Biologics, Janssen, Merck, and United Therapeutics" — before this language appears in any public-facing output, please confirm that referencing these firm names is appropriate. If any named firm would object, we need to use anonymized language.
- SMPS and Zweig marketing award winner — please confirm the specific award name(s) and year(s) for accurate use across all outputs.
Your intake listed "Brooke - Wright Mode" as a voice you want to sound like. Please confirm who or what this is so we can use their published work as a calibration sample in your brand voice file.
We plan to use LinkedIn native scheduling unless you tell us otherwise. If you have a preferred tool (Buffer, Hootsuite, or another), let us know before the first output batch is delivered.
The initial go-to-market strategy does not include an email newsletter. If you want to add one, confirm the platform you use or want to use and we will build that into the infrastructure.
Are there any companies or individuals that should never appear in your outputs or be targeted in outreach? If so, provide the list. If none, confirm so we can note this formally in your guardrails file.
Your Deliverables — What You're Receiving
These six files are your Backbone infrastructure. They are structured, usable, and portable — any team member, agency, or AI tool you work with can use them to stay consistent with your strategy.
Full buyer profiles for each segment — firmographics, OCEAN scores, buying triggers, journey stages, and what they need to see to say yes.
Your competitive position, five core differentiators, what you replace, and your boundary — the strategic layer behind every claim you make.
Archetypes, voice spectrum calibration, writing rules, and examples — everything needed to produce consistent, on-brand communications.
What you don't do, don't say, and don't represent — the explicit boundaries that protect brand credibility and keep all outputs on-strategy.
How the practice actually works — services, pricing model, delivery process, team structure, and engagement parameters. Context that makes outputs accurate.
Approved language, proven phrases, calibration examples, and on-brand references — the living library of what works.
Source Validation
This infrastructure was built entirely from your intake responses and your own published website and marketing materials. No third-party external sources were used.
| Source | Used For | Status |
|---|---|---|
| goodbonesmarketing.com | ICP audience profiles, brand voice analysis, positioning and differentiation language | Verified — client-owned |
| GBM-Flyer3.pdf | Sub-service descriptions, differentiators, founder credentials, ERA Science testimonial | Verified — client-owned |
Next Steps
Once you confirm this report is accurate, here is what happens:
- Your infrastructure activates. We apply any corrections you noted, finalize all six context files, and your Backbone Framework is live.
- First application. We generate your first LinkedIn content batch — 8 posts built directly from your infrastructure, delivered for your review before anything is published.
- Ongoing use. Your context files are yours to use for proposals, website copy, agency briefings, new hire onboarding, and any other marketing or BD output your organization needs.
If anything here doesn't match how you see your business, that is the right reaction. Use the notes fields above and submit your corrections below.
Submit Your Review
Once all five sections are approved, submitting sends your confirmations and notes to Good Bones Marketing.